位置:首页 > 蛋白库 > CBPZ_HUMAN
CBPZ_HUMAN
ID   CBPZ_HUMAN              Reviewed;         652 AA.
AC   Q66K79; O00520; Q96MX2;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Carboxypeptidase Z;
DE            Short=CPZ;
DE            EC=3.4.17.-;
DE   Flags: Precursor;
GN   Name=CPZ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, TISSUE SPECIFICITY, AND
RP   VARIANTS PRO-5; LEU-6 AND THR-486.
RX   PubMed=9099699; DOI=10.1074/jbc.272.16.10543;
RA   Song L., Fricker L.D.;
RT   "Cloning and expression of human carboxypeptidase Z, a novel
RT   metallocarboxypeptidase.";
RL   J. Biol. Chem. 272:10543-10550(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS
RP   PRO-5 AND THR-486.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10080937; DOI=10.1006/bbrc.1999.0378;
RA   Novikova E.G., Fricker L.D.;
RT   "Purification and characterization of human metallocarboxypeptidase Z.";
RL   Biochem. Biophys. Res. Commun. 256:564-568(1999).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10671522; DOI=10.1074/jbc.275.7.4865;
RA   Novikova E.G., Reznik S.E., Varlamov O., Fricker L.D.;
RT   "Carboxypeptidase Z is present in the regulated secretory pathway and
RT   extracellular matrix in cultured cells and in human tissues.";
RL   J. Biol. Chem. 275:4865-4870(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=11766880; DOI=10.1007/pl00000819;
RA   Reznik S.E., Fricker L.D.;
RT   "Carboxypeptidases from A to Z: implications in embryonic development and
RT   Wnt binding.";
RL   Cell. Mol. Life Sci. 58:1790-1804(2001).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12417617; DOI=10.1177/002215540205001111;
RA   Fan X., Olson S.J., Blevins L.S., Allen G.S., Johnson M.D.;
RT   "Immunohistochemical localization of carboxypeptidases D, E, and Z in
RT   pituitary adenomas and normal human pituitary.";
RL   J. Histochem. Cytochem. 50:1509-1516(2002).
CC   -!- FUNCTION: Cleaves substrates with C-terminal arginine residues.
CC       Probably modulates the Wnt signaling pathway, by cleaving some
CC       undefined protein. May play a role in cleavage during prohormone
CC       processing. {ECO:0000269|PubMed:11766880, ECO:0000269|PubMed:12417617,
CC       ECO:0000269|PubMed:9099699}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P00730};
CC   -!- ACTIVITY REGULATION: Inhibited by 2-mercaptomethyl-3-
CC       guanidinoethylthiopropanoic acid (MGTA) and
CC       guanidinoethylmercaptosuccinic acid (GEMSA). Inhibited by chelating
CC       agents such as EDTA and EGTA. {ECO:0000269|PubMed:9099699}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 mM for dansyl-Phe-Ala-Arg {ECO:0000269|PubMed:10080937,
CC         ECO:0000269|PubMed:9099699};
CC         KM=2 mM for dansyl-Pro-Ala-Arg {ECO:0000269|PubMed:10080937,
CC         ECO:0000269|PubMed:9099699};
CC       pH dependence:
CC         Optimum pH is 7.8. {ECO:0000269|PubMed:10080937,
CC         ECO:0000269|PubMed:9099699};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:10671522}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q66K79-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q66K79-2; Sequence=VSP_020983;
CC       Name=3;
CC         IsoId=Q66K79-3; Sequence=VSP_040356;
CC   -!- TISSUE SPECIFICITY: In placenta, it is present within invasive
CC       trophoblasts and in the surrounding extracellular space. Also present
CC       in amnion cells, but is not readily apparent in the extracellular
CC       matrix of this cell type. Present in normal pituitary gland and
CC       neoplastic pituitary gland (especially POMC-, GH- and PRL-producing
CC       adenomas) (at protein level). Widely expressed.
CC       {ECO:0000269|PubMed:10671522, ECO:0000269|PubMed:12417617,
CC       ECO:0000269|PubMed:9099699}.
CC   -!- SIMILARITY: Belongs to the peptidase M14 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB71147.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U83411; AAB58911.1; -; mRNA.
DR   EMBL; AK056317; BAB71147.1; ALT_FRAME; mRNA.
DR   EMBL; AC105345; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006393; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC080539; AAH80539.1; -; mRNA.
DR   CCDS; CCDS33953.1; -. [Q66K79-1]
DR   CCDS; CCDS3404.1; -. [Q66K79-2]
DR   CCDS; CCDS43212.1; -. [Q66K79-3]
DR   RefSeq; NP_001014447.1; NM_001014447.2. [Q66K79-1]
DR   RefSeq; NP_001014448.1; NM_001014448.2. [Q66K79-3]
DR   RefSeq; NP_003643.2; NM_003652.3. [Q66K79-2]
DR   AlphaFoldDB; Q66K79; -.
DR   SMR; Q66K79; -.
DR   BioGRID; 114102; 23.
DR   IntAct; Q66K79; 3.
DR   STRING; 9606.ENSP00000354255; -.
DR   MEROPS; M14.012; -.
DR   GlyGen; Q66K79; 1 site.
DR   iPTMnet; Q66K79; -.
DR   PhosphoSitePlus; Q66K79; -.
DR   BioMuta; CPZ; -.
DR   DMDM; 296434423; -.
DR   EPD; Q66K79; -.
DR   jPOST; Q66K79; -.
DR   MassIVE; Q66K79; -.
DR   PaxDb; Q66K79; -.
DR   PeptideAtlas; Q66K79; -.
DR   PRIDE; Q66K79; -.
DR   ProteomicsDB; 65958; -. [Q66K79-1]
DR   ProteomicsDB; 65959; -. [Q66K79-2]
DR   ProteomicsDB; 65960; -. [Q66K79-3]
DR   Antibodypedia; 22804; 64 antibodies from 22 providers.
DR   DNASU; 8532; -.
DR   Ensembl; ENST00000315782.6; ENSP00000315074.6; ENSG00000109625.19. [Q66K79-2]
DR   Ensembl; ENST00000360986.9; ENSP00000354255.4; ENSG00000109625.19. [Q66K79-1]
DR   Ensembl; ENST00000382480.6; ENSP00000371920.2; ENSG00000109625.19. [Q66K79-3]
DR   GeneID; 8532; -.
DR   KEGG; hsa:8532; -.
DR   MANE-Select; ENST00000360986.9; ENSP00000354255.4; NM_001014447.3; NP_001014447.2.
DR   UCSC; uc003glm.4; human. [Q66K79-1]
DR   CTD; 8532; -.
DR   DisGeNET; 8532; -.
DR   GeneCards; CPZ; -.
DR   HGNC; HGNC:2333; CPZ.
DR   HPA; ENSG00000109625; Tissue enhanced (ovary).
DR   MIM; 603105; gene.
DR   neXtProt; NX_Q66K79; -.
DR   OpenTargets; ENSG00000109625; -.
DR   PharmGKB; PA26854; -.
DR   VEuPathDB; HostDB:ENSG00000109625; -.
DR   eggNOG; KOG2649; Eukaryota.
DR   GeneTree; ENSGT00940000156391; -.
DR   HOGENOM; CLU_006722_5_1_1; -.
DR   InParanoid; Q66K79; -.
DR   OMA; RCAHIAK; -.
DR   OrthoDB; 101221at2759; -.
DR   PhylomeDB; Q66K79; -.
DR   TreeFam; TF315592; -.
DR   PathwayCommons; Q66K79; -.
DR   SignaLink; Q66K79; -.
DR   BioGRID-ORCS; 8532; 10 hits in 1064 CRISPR screens.
DR   GeneWiki; CPZ_(gene); -.
DR   GenomeRNAi; 8532; -.
DR   Pharos; Q66K79; Tbio.
DR   PRO; PR:Q66K79; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q66K79; protein.
DR   Bgee; ENSG00000109625; Expressed in left ovary and 98 other tissues.
DR   ExpressionAtlas; Q66K79; baseline and differential.
DR   Genevisible; Q66K79; HS.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006518; P:peptide metabolic process; IBA:GO_Central.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd03867; M14_CPZ; 1.
DR   Gene3D; 1.10.2000.10; -; 1.
DR   InterPro; IPR008969; CarboxyPept-like_regulatory.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR034239; M14_CPZ_CPD.
DR   InterPro; IPR000834; Peptidase_M14.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF00246; Peptidase_M14; 1.
DR   PRINTS; PR00765; CRBOXYPTASEA.
DR   SMART; SM00063; FRI; 1.
DR   SMART; SM00631; Zn_pept; 1.
DR   SUPFAM; SSF49464; SSF49464; 1.
DR   SUPFAM; SSF63501; SSF63501; 1.
DR   PROSITE; PS00133; CARBOXYPEPT_ZN_2; 1.
DR   PROSITE; PS50038; FZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carboxypeptidase; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Hydrolase; Metal-binding;
KW   Metalloprotease; Protease; Reference proteome; Secreted; Signal;
KW   Wnt signaling pathway; Zinc.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..652
FT                   /note="Carboxypeptidase Z"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000252456"
FT   DOMAIN          27..160
FT                   /note="FZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   REGION          595..629
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        472
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P14384"
FT   BINDING         248
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   BINDING         251
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   BINDING         380
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        43..109
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        51..102
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        93..129
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        118..157
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        122..146
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   VAR_SEQ         1..137
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040356"
FT   VAR_SEQ         30..40
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9099699"
FT                   /id="VSP_020983"
FT   VARIANT         5
FT                   /note="L -> P (in dbSNP:rs2302583)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9099699"
FT                   /id="VAR_027883"
FT   VARIANT         6
FT                   /note="P -> L (in dbSNP:rs34964084)"
FT                   /evidence="ECO:0000269|PubMed:9099699"
FT                   /id="VAR_047244"
FT   VARIANT         130
FT                   /note="Q -> L (in dbSNP:rs35993494)"
FT                   /id="VAR_047245"
FT   VARIANT         486
FT                   /note="I -> T (in dbSNP:rs7378066)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9099699"
FT                   /id="VAR_047246"
FT   VARIANT         501
FT                   /note="T -> M (in dbSNP:rs9991535)"
FT                   /id="VAR_027884"
FT   CONFLICT        200
FT                   /note="T -> M (in Ref. 4; BC006393)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="M -> I (in Ref. 1; AAB58911)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        523
FT                   /note="I -> T (in Ref. 2; BAB71147)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   652 AA;  73655 MW;  BFA1EA7753E63F98 CRC64;
     MPPPLPLLLL TVLVVAAARP GCEFERNPAG ECHRPPAADS ATCVDLQLRT CSDAAYNHTT
     FPNLLQHRSW EVVEASSEYI LLSVLHQLLE GQCNPDLRLL GCAVLAPRCE GGWVRRPCRH
     ICEGLREVCQ PAFDAIDMAW PYFLDCHRYF TREDEGCYDP LEKLRGGLEA DEALPSGLPP
     TFIRFSHHSY AQMVRVLRRT ASRCAHVART YSIGRSFDGR ELLVIEFSSR PGQHELMEPE
     VKLIGNIHGN EVAGREMLIY LAQYLCSEYL LGNPRIQRLL NTTRIHLLPS MNPDGYEVAA
     AEGAGYNGWT SGRQNAQNLD LNRNFPDLTS EYYRLAETRG ARSDHIPIPQ HYWWGKVAPE
     TKAIMKWMQT IPFVLSASLH GGDLVVSYPF DFSKHPQEEK MFSPTPDEKM FKLLSRAYAD
     VHPMMMDRSE NRCGGNFLKR GSIINGADWY SFTGGMSDFN YLHTNCFEIT VELGCVKFPP
     EEALYILWQH NKESLLNFVE TVHRGIKGVV TDKFGKPVKN ARISVKGIRH DITTAPDGDY
     WRLLPPGIHI VIAQAPGYAK VIKKVIIPAR MKRAGRVDFI LQPLGMGPKN FIHGLRRTGP
     HDPLGGASSL GEATEPDPLR ARRQPSADGS KPWWWSYFTS LSTHRPRWLL KY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024